Thermo Fisher Scientific (TMO) Non-Current Assets (2009 - 2026)

Thermo Fisher Scientific has disclosed Non-Current Assets across 18 years of filings, most recently posting $91.0 billion for Q1 2026.

• Quarterly Non-Current Assets rose 20.22% year-over-year to $91.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $330.0 billion (up 9.83% YoY) and the FY2025 annual result came in at $81.6 billion, up 8.58% from the prior year.
• Non-Current Assets rose to $91.0 billion in Q1 2026, from $81.6 billion in the prior quarter.
• Over five years, Non-Current Assets peaked at $91.0 billion in Q1 2026 and troughed at $71.2 billion in Q4 2022.
• A 5-year average of $75.9 billion and a median of $74.1 billion in 2023 frame the typical range for Non-Current Assets.
• Biggest YoY gain for Non-Current Assets was 53.32% in 2022; the steepest drop was 4.11% in 2022.
• Tracing TMO's Non-Current Assets over 5 years: stood at $71.9 billion in 2022, then climbed by 3.08% to $74.1 billion in 2023, then increased by 1.41% to $75.2 billion in 2024, then increased by 8.58% to $81.6 billion in 2025, then climbed by 11.43% to $91.0 billion in 2026.
• Business Quant data shows TMO's Non-Current Assets at $91.0 billion in Q1 2026, $81.6 billion in Q4 2025, and $80.7 billion in Q3 2025.